Pulmonary MR angiography with contrast agent at 4 Tesla: A preliminary result

In this study, pulmonary MR angiography (MRA) using a tailored coil at 4 Tesla in conjunction with an intravenous injection of contrast agent is described. Three‐dimensional gradient‐echo images were obtained during the intravenous injection of 0.05, 0.1, and 0.2 mmol/kg body weight of gadodiamide to investigate the signal enhancement effect of the contrast agent in pulmonary arteries qualitatively and quantitatively. In the qualitative analysis, the subsegmental branches were visualized on every dose. In the quantitative analysis, the average contrast‐to‐noise ratios (CNRs) of the main pulmonary arteries increased in a dose‐dependent manner. However, the CNRs of segmental arteries did not increase as the dose of contrast agent increased, as observed at 1.5 Tesla MRI. These observations demonstrate the feasibility of delineating the pulmonary vasculature using a contrast agent; however, our results also suggest possible high‐field‐related disabilities that need to be overcome before high‐field (≥4 Tesla) MRI can be used to full advantage. Magn Reson Med 46:1028–1030, 2001. © 2001 Wiley‐Liss, Inc.

[1]  L. Dougherty,et al.  Cardiac imaging at 4 Tesla , 2001, Magnetic resonance in medicine.

[2]  A. Kangarlu,et al.  Ultra high resolution imaging of the human head at 8 tesla: 2K x 2K for Y2K. , 2000, Journal of computer assisted tomography.

[3]  D. Roberts,et al.  Magnetization transfer imaging of the brain: A quantitative comparison of results obtained at 1.5 and 4.0 t , 1999, Journal of magnetic resonance imaging : JMRI.

[4]  J Listerud,et al.  T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. , 1999, European journal of radiology.

[5]  K. Thulborn Clinical rationale for very-high-field (3.0 Tesla) functional magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.

[6]  H. Hatabu,et al.  Fast magnetic resonance imaging of the lung. , 1999, European journal of radiology.

[7]  J. Debatin,et al.  Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. , 1998, Magnetic resonance imaging.

[8]  Klaus Scheffler,et al.  Contrast-Enhanced Magnetic Resonance Angiography of Peripheral Vessels: Different Contrast Agent Applications and Sequence Strategies , 1998 .

[9]  W. Steinbrich,et al.  Contrast-enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies: a review. , 1998, Investigative radiology.

[10]  R. Edelman,et al.  Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. , 1996, AJR. American journal of roentgenology.

[11]  R S Balaban,et al.  MR relaxation times in human brain: measurement at 4 T. , 1996, Radiology.

[12]  J M Pauly,et al.  Lung parenchyma: projection reconstruction MR imaging. , 1991, Radiology.

[13]  Magnetic resonance contrast media: principles and progress. , 1990, Magnetic resonance quarterly.

[14]  Protocols and test objects for the assessment of MRI equipment. EEC Concerted Research Project. , 1988, Magnetic resonance imaging.

[15]  P A Bottomley,et al.  RF magnetic field penetration, phase shift and power dissipation in biological tissue: implications for NMR imaging. , 1978, Physics in medicine and biology.